Same Song, Different Audience: Pharmaceutical Promotion Targeting Non-Physician Health Care Providers

article has not abstract

Vyšlo v časopise: Same Song, Different Audience: Pharmaceutical Promotion Targeting Non-Physician Health Care Providers. PLoS Med 10(11): e32767. doi:10.1371/journal.pmed.1001560
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001560

Souhrn

article has not abstract

Zdroje

1. Greene JA (2007) Prescribing by numbers: drugs and the definition of disease. Baltimore: Johns Hopkins University Press.

2. WazanaA (2000) Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 283 : 373–80.

3. AvornJ, ChenM, HartleyR (1982) Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 73 : 4–8.

4. RobertsonC, RoseS, KesselheimAS (2012) Effect of financial relationships on the behaviors of health care professionals: a review of the evidence. J Law Med Ethics 40 : 452–66.

5. BrennanTA, RothmanDJ, BlankL, et al. (2006) Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 295 : 429–33.

6. ChimonasS, PattersonL, RaveisVH, RothmanDJ (2011) Managing conflicts of interest in clinical care: a national survey of policies at U.S. medical schools. Acad Med 86 : 293–9.

7. RothmanDJ (2008) Academic medical centers and financial conflicts of interest. JAMA 299 : 695–7.

8. National Payment Physician Transparency Program (2013) Available: http://www.cms.gov/Regulations-and-Guidance/Legislation/National-Physician-Payment-Transparency-Program/index.html. Accessed 15 October 2013.

9. HillKP, RossJS, EgilmanDS, KrumholzHM (2008) The ADVANTAGE seeding trial: a review of internal documents. Ann Intern Med 149 : 251–8.

10. RoseSL (2013) Patient Advocacy Organizations: Institutional Conflicts of Interest, Trust, and Trustworthiness. J Law Med Ethics 41 (3) 680–687.

11. DrussBG, MarcusSC, OlfsonM, TanielianT, PincusHA (2003) Trends in care by nonphysician clinicians in the United States. N Engl J Med 348 : 130–7.

12. JutelA, MenkesDB (2008) Soft Targets: Nurses and the Pharmaceutical Industry. PLoS Med 5 (2) e5 doi:10.1371/journal.pmed.0050005

13. GrundyQ, BeroL, MaloneR (2013) Interactions between non-physician clinicians and industry: A systematic review. PLoS Med (10)11: e1001561doi: 10.1371/journal.pmed.1001561

14. CampbellEG (2007) Doctors and drug companies—scrutinizing influential relationships. N Engl J Med 357 : 1796–7.

15. KesselheimAS, RobertsonCT, SiriK, BatraP, FranklinJM (2013) Distributions of industry payments to Massachusetts physicians. N Engl J Med 368 : 2049–52.

16. CampbellEG, RaoSR, DesRochesCM, et al. (2010) Physician professionalism and changes in physician–industry relationships from 2004 to 2009. Arch Intern Med 170 : 1820–6.

17. Partners Policy for Interactions with Industry and Other Outside Entities (2012) Available: http://www.partners.org/Assets/Documents/About-Us/OII/OII_Policy.pdf. Accessed 27 September 2013.

18. AustadKE, AvornJ, FranklinJM, KesselheimAS (2013) Physician Trainees' Interactions with the Pharmaceutical Industry. J Gen Internl Med 28 (10) 1267.